METHODS: Four client-owned horses with primary (n = 2) or secondary (n = 2) glaucoma.
METHODS: Horses were treated with MP-TSCPC under standing sedation with a minimum of 30 days of follow-up (range 30-1241 days). Affected eyes were treated with a 31.3% duty cycle and 3000 mW laser power for a total of 180 s. Data collected included signalment, pre- and post-procedure intraocular pressures (IOPs), laser settings, medications, complications, and repeat therapy.
RESULTS: Four horses (5 eyes) received at least one treatment with MP-TSCPC. Mean preoperative IOP was 44 mmHg (range 33-49 mmHg). The immediate mean postoperative IOP was 34 mmHg (4 eyes; range 19-55 mmHg). At 1 week, IOP was 38 mmHg (5 eyes; range 21-80 mmHg), at 2 weeks was 40 mmHg (3 eyes, range 17-80 mmHg), at 1 month was 35 mmHg (5 eyes; range 20-50 mmHg), at 3 months was 18 mmHg (2 eyes; range 14-21 mmHg), at 6 months was 35 mmHg (2 eyes; range 30-39 mmHg), and at >300 days was 24 mmHg (3 eyes; range 18-29 mmHg). Complications included corneal ulceration (n = 1 eye), uncontrolled IOP (n = 3 eyes), and need for repeat treatment (n = 2 eyes).
CONCLUSIONS: MP-TSCPC used with the above-described settings was unsuccessful in treating the majority of cases. Future studies should be targeted at primary glaucoma cases and with use of alternative laser settings.
方法:四匹主养马患有原发性(n=2)或继发性(n=2)青光眼。
方法:马在站立镇静下接受MP-TSCPC治疗,至少随访30天(范围30-1241天)。受影响的眼睛用31.3%的占空比和3000mW的激光功率治疗180s。收集的数据包括信号,术前和术后眼压(IOP),激光设置,药物,并发症,和重复治疗。
结果:四匹马(5只眼)接受了至少一次MP-TSCPC治疗。术前平均IOP为44mmHg(范围33-49mmHg)。术后即刻平均IOP为34mmHg(4眼;范围19-55mmHg)。在1周,IOP为38mmHg(5眼,范围21-80mmHg),2周时为40mmHg(3眼,范围17-80mmHg),1个月时为35mmHg(5只眼;范围20-50mmHg),3个月时为18mmHg(2眼;范围14-21mmHg),6个月时为35mmHg(2只眼;范围30-39mmHg),在>300天时为24mmHg(3眼;范围18-29mmHg)。并发症包括角膜溃疡(n=1眼),IOP失控(n=3只眼睛),需要重复治疗(n=2只眼)。
结论:与上述设置一起使用的MP-TSCPC无法成功治疗大多数病例。未来的研究应针对原发性青光眼病例,并使用替代激光设置。